INDV-2000

DRUG4 trials

Sponsors

Indivior Inc.

Conditions

HealthyHealthy VolunteerOpioid DependenceOpioid Use DisorderOpioid-use Disorder

Phase 1

INDV-2000 First in Human

CompletedNCT04413552

Indivior Inc.Opioid Dependence

Start: 2020-07-06End: 2021-04-13Updated: 2024-05-16

Study to Assess Repeated Doses of INDV-2000 in Healthy Volunteers and in Treatment Seeking Individuals With Opioid Use Disorder

CompletedNCT04976855

Indivior Inc.Healthy Volunteer, Opioid-use Disorder

Start: 2022-08-17End: 2023-07-05Updated: 2024-08-21

Study of Potential CYP3A4 Induction by INDV-2000 in Healthy Adults

CompletedNCT05694533

Indivior Inc.Healthy

Start: 2023-03-16End: 2023-05-01Updated: 2024-05-28

Phase 2

Proof of Concept and Dose-ranging Study of INDV-2000 in Individuals With Moderate to Severe Opioid Use Disorder

CompletedNCT06384157

Indivior Inc.Opioid Use Disorder

Start: 2024-06-10End: 2025-11-03Updated: 2025-12-16